University of Milan at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Milan brings 3 presentations to ASH 2026 in New Orleans. Its program centres on myelofibrosis, transplant complications and autoimmune hemolytic anemia. Work covers obexelimab in warm AIHA, mitapivat response by genotype and blast-phase CML genomics.
| Organization | ASH 2026 Attendance |
|---|---|
University of Milan Milan, Italy | |
Public research university in Milan, Italy, with a large medical faculty. | Symposium Fri Dec 11 3:00pm–6:00pm A Case-Based Exploration of Current and Future Directions in Myelofibrosis – Where We Are, Where We’re Going Real patient cases showing how experts treat myelofibrosis today, paired with reviews of current data and ongoing research on emerging therapies. Symposium Fri Dec 11 7:00pm–10:00pm Cases and Conversations: Endothelial Injury, Complement, and TA-TMA After Allogeneic Stem Cell Transplant Picking graft sources such as expanded cord blood, and treating transplant-associated thrombotic microangiopathy with a newly approved complement inhibitor. Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm |
Find decision makers at University of Milan
Tell us what you sell and we’ll find the people at University of Milan most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction